Insider Transactions in Q4 2024 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,884
-3.33%
|
$1,884
$1.9 P/Share
|
|
Oct 25
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+9.94%
|
-
|
|
Oct 03
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
5,598
-2.32%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,361
-6.58%
|
$3,361
$1.96 P/Share
|
|
Oct 03
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,598
-10.0%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,598
-8.08%
|
$5,598
$1.96 P/Share
|
|
Oct 03
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
5,598
-5.57%
|
$5,598
$1.96 P/Share
|
|
Oct 02
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,089
-3.24%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,855
-8.67%
|
$9,710
$2.0 P/Share
|
|
Oct 02
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
8,089
-12.63%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,089
-10.45%
|
$16,178
$2.0 P/Share
|
|
Oct 02
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
8,089
-7.45%
|
$16,178
$2.0 P/Share
|
|
Oct 01
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+16.7%
|
-
|
|
Oct 01
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+34.89%
|
-
|
|
Oct 01
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.84%
|
-
|
|
Oct 01
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+39.25%
|
-
|
|
Oct 01
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.54%
|
-
|